Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 152
- CBD Market
Cookies Stores To Open On UK And Continental High Streets In Coming Weeks
INTERCURE, which calls itself the ‘most profitable and fastest growing’ cannabis company outside of North America, is poised to open a number of cannabis shops on UK high streets.
- CBD Market
Investors Respond Positively To Senior Appointment At Under-Fire UK CBD Firm
CHILL Brands Group saw its stock prices jump as much as 25% after announcing the appointment of Michael Sandore as its new head of sales and marketing.
- News
Buy-And-Build Cannabis Company Pivots to Adult-Use Opportunities In Its Domestic Market
GERMAN firm SynBiotic has just completed what it calls the ‘most significant merger in the European cannabis sector’ to date, as it considers how best to position itself to capitalise on the incoming recreational opportunity.
- News
After Securing Cultivation Licence Guernsey-Based 4C Labs Will Open UK Medical Cannabis Tele-Clinics
4C LABS has officially received a specialist clinic licence from the UK’s Care Quality Commission (CQC), enabling it to launch virtual health clinics in the coming year.
- Adult-Use
Malta Officially Votes To Become The First EU State to Decriminalise Recreational Cannabis
MALTA will now become the first European country to legalise cannabis for recreational use, with legislation expected to come into force over the coming days.
- CBD Market
Hemp Pioneer On The $11.2m Sale Of His Business And The Decade’s ‘Most Exciting Industry’
EUROPEAN cannabis industry ‘pioneer’ Daniel Kruse believes that Germany is poised to ‘lead the way for a new global drug policy’.
- Pharmaceutical
London Stock Exchange Cannabis Company Values Down Almost £200m From Early Peaks
THIS has been a transformative year for the European cannabis industry, with growing liberalisation across the continent opening the floodgates for patients and investors alike.
- CBD Market
Cellular Goods Appoints New CEO As It Launches First Products Following £3m Loss
CELLULAR Goods has announced that health and beauty industry veteran Anna Chokina has replaced Alexis Abraham as its new CEO with immediate effect.
- Pharmaceutical
High-Profile Director Quits Oxford Cannabinoid Technologies Board Following Chairman’s Recent Departure
Oxford Cannabinoid Technologies (OCT) has seen its second senior departure in under a month as it begins to recover from the fallout of a credit deal which breached market rules.
- Pharmaceutical
Work To Start On UK Mainland’s First Commercial Cannabis Cultivation Facility For Over 20 Years
GLASS Pharms has agreed a £22.5m funding deal to build the UK mainland’s first, high-THC, commercial cultivation facility for over 20 years.
- Markets & Stocks
MGC Pharmaceuticals Tells Shareholders Pending Deal Could ‘Transform Finances Overnight’
MGC Pharmaceuticals told shareholders attending its Annual General Meeting (AGM) that it is on track to deliver ‘far and away the best financial performance of the company’ in the coming months.
- CBD Market
Yooma Aiming For Annual Revenues Of $20m-Plus With Buying Spree Set To Continue
YOOMA Wellness saw revenues decline in its third quarter but managed to taper losses as it continued to buy up international CBD and wellness brands at pace.
